Assignee
ABMAX BIOTECHNOLOGY CO LTD
CN·1 granted patent·2 pending applications·1 citations·filing 2015–2020
Top patents by PatentIndex Score
3 records- 0161US10941196B2Anti-TNF-α fully human monoclonal antibodies with low immunogenicity and application thereofABMAX BIOTECHNOLOGY CO LTD·Filed 2015·Granted Mar 9, 2021·1 cites·2 claims
- 0255US2021198354A1Method for treating autoimmune and inflammatory diseasesABMAX BIOTECHNOLOGY CO LTD·Filed 2020·Application pending·0 cites
- 0340US2024067745A1Anti-C5 humanized monoclonal antibody with low immunogenicity and low ADCC/CDC function and its applicationABMAX BIOTECHNOLOGY CO LTD·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when ABMAX BIOTECHNOLOGY CO LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →